131 related articles for article (PubMed ID: 11063649)
21. Diagnostic value of endocervical curettage for detecting dysplastic lesions in women with atypical squamous cells of undetermined significance (ASC-US) and low grade squamous intraepithelial lesion (LSIL) Papanicolaou smears.
Poomtavorn Y; Suwannarurk K; Thaweekul Y; Maireang K
Asian Pac J Cancer Prev; 2014; 15(8):3461-4. PubMed ID: 24870740
[TBL] [Abstract][Full Text] [Related]
22. Comparison of human papillomavirus DNA testing and repeat Papanicolaou test in women with low-grade cervical cytologic abnormalities: a randomized trial. HPV Effectiveness in Lowgrade Paps (HELP) Study No. 1 Group.
Lytwyn A; Sellors JW; Mahony JB; Daya D; Chapman W; Ellis N; Roth P; Lorincz AT; Gafni A
CMAJ; 2000 Sep; 163(6):701-7. PubMed ID: 11022584
[TBL] [Abstract][Full Text] [Related]
23. [Wait-and-see policy versus loop excision after two consecutive Pap-2 cervical smears: over time less surgery and an equivalent outcome; no substantial contribution to be expected from the detection of high risk human papillomavirus].
Bekkers RL; Hanselaar AG; Melchers WJ; van Schaik JH; Boonstra H; Massuger LF
Ned Tijdschr Geneeskd; 2003 Feb; 147(7):302-6. PubMed ID: 12622008
[TBL] [Abstract][Full Text] [Related]
24. The incidental finding of abnormal cervical histology in postmenopausal patients.
Gerbaldo D; Cristoforoni P; Leone M; Casciaro L; Baracchini P; Fulcheri E
Maturitas; 1995 Feb; 21(2):115-20. PubMed ID: 7752948
[TBL] [Abstract][Full Text] [Related]
25. Characteristic findings of cervical Papanicolaou tests from transgender patients on androgen therapy: Challenges in detecting dysplasia.
Adkins BD; Barlow AB; Jack A; Schultenover SJ; Desouki MM; Coogan AC; Weiss VL
Cytopathology; 2018 Jun; 29(3):281-287. PubMed ID: 29488269
[TBL] [Abstract][Full Text] [Related]
26. Expression of p16 INK4A in Papanicolaou smears containing atypical squamous cells of undetermined significance from the uterine cervix.
Nieh S; Chen SF; Chu TY; Lai HC; Fu E
Gynecol Oncol; 2003 Oct; 91(1):201-8. PubMed ID: 14529682
[TBL] [Abstract][Full Text] [Related]
27. Managing atypical squamous cells of undetermined significance in Papanicolaou smears.
Morin C; Bairati I; Bouchard C; Fortier M; Roy M; Moore L; Meisels A
J Reprod Med; 2001 Sep; 46(9):799-805. PubMed ID: 11584480
[TBL] [Abstract][Full Text] [Related]
28. CINtec® PLUS dual immunostain: a triage tool for cervical pap smears with atypical squamous cells of undetermined significance and low grade squamous intraepithelial lesion.
Loghavi S; Walts AE; Bose S
Diagn Cytopathol; 2013 Jul; 41(7):582-7. PubMed ID: 22833355
[TBL] [Abstract][Full Text] [Related]
29. Accuracy of liquid-based Pap tests: comparison of concurrent liquid-based tests and cervical biopsies on 782 women with previously abnormal Pap smears.
Guo M; Hu L; Martin L; Liu S; Baliga M; Hughson MD
Acta Cytol; 2005; 49(2):132-8. PubMed ID: 15839615
[TBL] [Abstract][Full Text] [Related]
30. Improved abnormal Pap smear triage using cervical cancer biomarkers.
Killeen JL; Dye T; Grace C; Hiraoka M
J Low Genit Tract Dis; 2014 Jan; 18(1):1-7. PubMed ID: 23760145
[TBL] [Abstract][Full Text] [Related]
31. [Verification of doubtful PAP smear results of women included in the screening program in the Podlaskie province].
Błońska E; Knapp PA
Ginekol Pol; 2013 Aug; 84(8):691-5. PubMed ID: 24191502
[TBL] [Abstract][Full Text] [Related]
32. Ki-67 immunostaining in Pap smears of cervix: assessment of proliferation in preinvasive and invasive squamous epithelial lesions.
Pahuja S; Choudhury M; Gupta U
Indian J Pathol Microbiol; 2004 Jan; 47(1):1-3. PubMed ID: 15471112
[TBL] [Abstract][Full Text] [Related]
33. Utility of p16, Ki-67, and HPV test in diagnosis of cervical intraepithelial neoplasia and atrophy in women older than 50 years with 3- to 7-year follow-up.
Jackson JA; Kapur U; Erşahin Ç
Int J Surg Pathol; 2012 Apr; 20(2):146-53. PubMed ID: 22104735
[TBL] [Abstract][Full Text] [Related]
34. The clinical significance of atypical squamous cells of undetermined significance: a laboratory audit of cervical reporting.
Roche DH; Spicer N
N Z Med J; 2001 Feb; 114(1126):64-6. PubMed ID: 11280428
[TBL] [Abstract][Full Text] [Related]
35. CIN 2/3 and cervical cancer after an ASCUS pap smear. A 7-year, prospective study of the Norwegian population-based, coordinated screening program.
Nygård JF; Sauer T; Skjeldestad FE; Skare GB; Thoresen SØ
Acta Cytol; 2003; 47(6):991-1000. PubMed ID: 14674068
[TBL] [Abstract][Full Text] [Related]
36. The Incidence and Clinical Significance of Atypical Glandular Cells of Undetermined Significance on Cervical Pap Smears.
Al-Rayyan E; Rashed M; Maaita M; Qudah S; Taso O; Haddadin W
Gulf J Oncolog; 2019 May; 1(30):52-56. PubMed ID: 31242982
[TBL] [Abstract][Full Text] [Related]
37. Value of histiocyte detection in Pap smears for predicting endometrial pathology. An institutional experience.
Nassar A; Fleisher SR; Nasuti JF
Acta Cytol; 2003; 47(5):762-7. PubMed ID: 14526675
[TBL] [Abstract][Full Text] [Related]
38. Patients with negative cervical biopsies after papanicolaou test interpretations of "atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion": comparative longitudinal follow-up.
Huitron S; Bonvicino A; Fadare O
Ann Diagn Pathol; 2008 Jun; 12(3):187-90. PubMed ID: 18486894
[TBL] [Abstract][Full Text] [Related]
39. Genomic amplification of the human telomerase gene (TERC) in pap smears predicts the development of cervical cancer.
Heselmeyer-Haddad K; Sommerfeld K; White NM; Chaudhri N; Morrison LE; Palanisamy N; Wang ZY; Auer G; Steinberg W; Ried T
Am J Pathol; 2005 Apr; 166(4):1229-38. PubMed ID: 15793301
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the atypical Pap smear.
Jones DE; Creasman WT; Dombroski RA; Lentz SS; Waeltz JL
Am J Obstet Gynecol; 1987 Sep; 157(3):544-9. PubMed ID: 3631155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
